Top 3 growth shares to buy in November 2021

Our writer considers three top growth shares to buy for his portfolio today and explains why he likes their business models and future prospects.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

I’m always on the lookout for growth shares to buy for my portfolio. Here are three I would consider this month.

Lab instrument specialist: Judges Scientific

I reckon scientific instrument manufacturer Judges Scientific (LSE: JDG) could continue its impressive record of long-term growth.

The company’s approach is simple. It buys up instrument makers, using a disciplined approach to valuation to avoid overpaying. The benefits of being part of a larger company can allow such subsidiaries room to grow and extra financial flexibility. But head office doesn’t interfere too much with operations. As precision is important in scientific instruments, customers are willing to pay a premium for quality products. That gives Judges pricing power and has allowed it to raise its dividend by double digits for a few years in a row.

There are risks, though. For example, sustained lab closures in some markets could dent revenues and profits over the next couple of years.

International sportswear retailer: JD Sports

While JD Sports (LSE: JD) may seem like a homegrown success story, much of its recent growth trajectory is down to its international expansion. That builds on what the retail giant has learnt in four decades of operation. It is expert at identifying customer needs, buying the right assortment of products, and merchandising them well.

That shows through in JD’s performance. Its blockbuster interim results – which saw the company’s best ever half-year profits – suggest that the growth trajectory continues. But it isn’t all smooth sailing. For example, if logistics problems continue, they could hurt growth and profits to boot. Over the long term, however, I continue to see substantial opportunities for growth. I think that could propel the JD Sports share price to new highs.

Established drinks maker: Diageo

Looking at drinks trends in recent years, from the popularity of niche premium spirits to a growing interest in alcohol-free alternatives, one company that seems to benefit from many of them is manufacturer Diageo (LSE: DGE). With premium spirits brands like Aviator Gin, teetotal tipple Seedlip, and massive premium brands like Johnnie Walker, the company is a powerhouse in the lucrative drinks market.

It isn’t resting on its laurels, as the huge new Johnnie Walker whisky centre on Edinburgh’s Princes Street shows. I expect continued growth in coming years. That will hopefully come from a combination of careful brand stewardship, customer demand for premium drinks and pricing power. But there are risks here too. Seedlip might not be enough to protect the company’s revenues from a growing tendency among younger drinkers to shun alcohol.

Growth shares to buy and hold

High-quality growth shares can be expensive. These three shares aren’t cheap based on a price-to-earnings valuation. Share price performance in any given period could be hurt by weak results. Over the long term, however, I reckon their high-quality operations in different fields can support both revenue and profit growth. I would happily add all three to my portfolio this month.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Christopher Ruane has no position in any shares mentioned. The Motley Fool UK has recommended Diageo and Judges Scientific. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »